MDxHealth Q4 Revenues Down 43 Percent, Continues Preparation for Prostate Cancer Test Launch | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDx Health today reported that revenues in the third quarter declined 43 percent year over year.

For the period ended September 30, total revenues were €378,000 ($511,000), down from €669,000 a year ago, with commercial revenues of €267,000 down 41 percent from €451,000 a year ago.

Net loss for the quarter increased 27 percent to €1.9 million from a net loss of €1.5 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.